Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2-breast cancer: comparison to the morphological and pathological response

被引：0
|
作者：
Boughdad, Sarah [1 ]
Champion, Laurence [1 ]
Becette, Veronique [2 ]
Cherel, Pascal [2 ]
Mouret-Fourme, Emmanuelle [2 ]
Edeline, Veronique [1 ]
Lemonnier, Jerome [3 ]
Lerebours, Florence [2 ]
Alberini, Jean-Louis [1 ]
机构：
[1] Ctr Rene Huguenin, Inst Curie, Nucl Med, St Cloud, France
[2] Ctr Rene Huguenin, Inst Curie, St Cloud, France
[3] Unicancer, Paris, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1311
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Genomic characterization and oncology outcomes of a locally advanced ER+/HER2-breast cancer cohort treated with neoadjuvant chemotherapy
    Abreu, Maira
    Furlan, Larissa
    Ma, Yutong
    Chen, Hanlin
    Ferreira, Carla
    Fares, Aline
    Constantino, Eduardo
    Nora, Gustavo R.
    Lucio, Gabriela
    Colombo, Tatiana
    Liu, Rui
    Wu, Xue
    Ou, Qiuxiang
    Araujo, Daniel V.
    CANCER RESEARCH, 2023, 83 (05)
  • [32] Neoadjuvant (Z)-endoxifen in premenopausal ER+, HER2-breast cancer: Evaluation of the first pharmacokinetic cohort of the EVANGELINE trial
    Goetz, Matthew P.
    Suman, Vera J.
    Fraser, Heather
    Mina, Lida
    Advani, Pooja
    Leon-Ferre, Roberto
    Giridhar, Karthik
    Batalini, Felipe
    Hunt, Katie N.
    Jayaraman, Swaathi
    Jakub, James
    Cronin, Patricia
    Piltin, Mara
    Degnim, Amy
    Ingle, James N.
    Boughey, Judy C.
    Buhrow, Sarah
    Reid, Joel
    Schellenberg, Matthew
    Hawse, John
    Quay, Steven
    CANCER RESEARCH, 2024, 84 (07)
  • [33] Gene signatures as potential predictive markers of response to neoadjuvant chemotherapy in ER+/HER2+breast cancer patients
    Risi, E.
    Grilli, A.
    Migliaccio, I.
    Biagioni, C.
    Guarducci, C.
    Bonechi, M.
    McCartney, A.
    Vitale, S.
    Biganzoli, L.
    Bicciato, S.
    Di Leo, A.
    Malorni, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Predictive model algorithms identifying early and advanced stage ER+/HER2-breast cancer in claims data
    Beachler, Daniel C.
    de Luise, Cynthia
    Yin, Ruihua
    Gangemi, Kelsey
    Cochetti, Philip T.
    Lanes, Stephan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (02) : 171 - 178
  • [35] EndoPredict-based treatment decision can reduce chemotherapy usage in ER+, HER2-breast cancer
    Schlake, G.
    Kronenwett, R.
    Tiecke, F.
    Kastrup, K.
    Bleuel, N.
    Petry, C.
    Wilhelms, S.
    Toennies, P.
    Schlake, W.
    BREAST, 2015, 24 : S107 - S107
  • [36] Is 18FDG uptake useful to decide on chemotherapy in ER+/HER2-breast cancer?
    Groheux, David
    Hindie, Elif
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) : 1571 - 1573
  • [37] Discovery of CDK4/6 bifunctional degraders for ER+/HER2-breast cancer
    Majeski, Hannah
    Okano, Akinori
    Pasis, Angela
    Carlson, Casey
    Shakya, Arvind
    Huang, Shenlin
    Chourasia, Aparajita Hoskote
    Fung, Leah M.
    Liu, Qiao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER+ HER2- Breast Cancer: A Prospective Phase II Study
    Hayashi, Naoki
    Yagata, Hiroshi
    Tsugawa, Koichiro
    Kajiura, Yuka
    Yoshida, Atsushi
    Takei, Junko
    Yamauchi, Hideko
    Nakamura, Seigo
    CLINICAL BREAST CANCER, 2020, 20 (06) : 462 - 468
  • [39] Incidence of Pulmonary Embolism Among Postmenopausal (PM) Women with ER+/HER2-Breast Cancer
    Zhou, Xiaofeng
    de Luise, Cynthia
    Shen, Rongjun
    Bate, Andrew
    Gatto, Nicolle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 372 - 373
  • [40] MODERN CHEMOTHERAPY USE AMONG YOUNG WOMEN WITH EARLYSTAGE ER+/HER2-BREAST CANCER
    Poorvu, Philip
    Gelber, Shari
    Rosenberg, Shoshana
    Ruddy, Kathryn
    Tamimi, Rulla
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia
    Come, Steven
    Collins, Laura
    Warner, Ellen
    Partridge, Ann
    BREAST, 2018, 41 : S18 - S18
12345